VIVIMEDLAB.BO
Healthcare Drug Manufacturers - Specialty & GenericVivimed Labs Limited
₹6.48
+0.30 +4.85% today Live
Price History
Not enough data
| Date | Price |
|---|---|
| Oct 7, 2026, live at 10:06 AM ET | 6.48 |
Key Stats
Market Cap
537.28M
Avg Volume
—
EPS
-₹2.93
52W High
₹27.99
52W Low
₹4.90
Div. Yield
0.0%
Valuation
Forward P/E
0.54
P/B Ratio
-1.12
P/S Ratio
0.49
EV/EBITDA
195.62
EV/Revenue
4.09
Margins
Gross Margin 52.5%
Operating Margin (27.1%)
Net Margin (22.4%)
EBITDA Margin 2.1%
Growth & Returns
Revenue Growth (YoY)
(16.0%)
Liquidity & Leverage
Current Ratio
0.78
Quick Ratio
0.21
Total Cash
10.12M
Total Debt
3.84B
About
Vivimed Labs Limited, together with its subsidiaries, manufactures and sells active pharmaceutical ingredients (APIs), finished dosage formulations, specialty chemicals, and retail branded formulations in India. It operates through two segments, Speciality Chemicals Business and Pharma Business. The company provides APIs and intermediates to generic and ethical companies; and branded formulations in therapeutic segments, such as ophthalmic, nutraceuticals, dermatology, and pain, as well as contract manufacturing of capsules and tablets, syrups and liquids, and nasal sprays and ointments. It also exports its products. The company was incorporated in 1988 and is based in Hyderabad, India.
www.vivimedlabs.com